Evidence map›Paper›PMID 35698033›Full record

ArticleBMC bioinformatics2022

CARE 2.0: reducing false-positive sequencing error corrections using machine learning.

Felix Kallenborn, Julian Cascitti, Bertil Schmidt

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A survey of k-mer methods and applications in bioinformatics.Computational and structural biotechnology journal · 2024
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Felix KallenbornDepartment of Computer Science, Johannes Gutenberg University Mainz, Mainz, Germany. kallenborn@uni-mainz.de.ORCID http://orcid.org/0000-0003-4516-6357
Julian CascittiDepartment of Computer Science, Johannes Gutenberg University Mainz, Mainz, Germany.
Bertil SchmidtDepartment of Computer Science, Johannes Gutenberg University Mainz, Mainz, Germany.ORCID https://orcid.org/0000-0003-2597-8331
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNext-generation sequencing pipelines often perform error correction as a preprocessing step to obtain cleaned input data. State-of-the-art error correction programs are able to reliably detect and correct the majority of sequencing errors. However, they also introduce new errors by making false-positive corrections. These correction mistakes can have negative impact on downstream analysis, such as k-mer statistics, de-novo assembly, and variant calling. This motivates the need for more precise error correction tools.

resultsWe present CARE 2.0, a context-aware read error correction tool based on multiple sequence alignment targeting Illumina datasets. In addition to a number of newly introduced optimizations its most significant change is the replacement of CARE 1.0's hand-crafted correction conditions with a novel classifier based on random decision forests trained on Illumina data. This results in up to two orders-of-magnitude fewer false-positive corrections compared to other state-of-the-art error correction software. At the same time, CARE 2.0 is able to achieve high numbers of true-positive corrections comparable to its competitors. On a simulated full human dataset with 914M reads CARE 2.0 generates only 1.2M false positives (FPs) (and 801.4M true positives (TPs)) at a highly competitive runtime while the best corrections achieved by other state-of-the-art tools contain at least 3.9M FPs and at most 814.5M TPs. Better de-novo assembly and improved k-mer analysis show the applicability of CARE 2.0 to real-world data.

conclusionFalse-positive corrections can negatively influence down-stream analysis. The precision of CARE 2.0 greatly reduces the number of those corrections compared to other state-of-the-art programs including BFC, Karect, Musket, Bcool, SGA, and Lighter. Thus, higher-quality datasets are produced which improve k-mer analysis and de-novo assembly in real-world datasets which demonstrates the applicability of machine learning techniques in the context of sequencing read error correction. CARE 2.0 is written in C++/CUDA for Linux systems and can be run on the CPU as well as on CUDA-enabled GPUs. It is available at https://github.com/fkallen/CARE .

Indexed as

AlgorithmsSoftwareHigh-Throughput Nucleotide SequencingHumansMachine LearningSequence AlignmentSequence Analysis, DNAError correctionMachine learningNext-generation sequencing

Identifiers

PMID35698033
PMCPMC9195321
OpenAlexW4282566492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.